Page - 1 of 1


HIVsir IDHIV StrainNCBI AccessionTarget GenePosition of siRNA targetSense Sequence of siRNAEfficacy (%)Target Conservation *Cell linePubMed
1086HIV-1 (NL4-3)AF324493Vpu6203AAGAGCAGAAGACAGUGGCAA95.00849(56.75%)293 T15750613
1087HIV-1(P89)K02013Vpu6211AAGACAGUGGCAAUGAGAGUG93.00756(50.53%)293 T15750613
1088HIV-1 (NL4-3)AF324493Vpu6211AAGACAGUGGCAAUGAGAGUG95.00756(50.53%)293 T15750613
1486HIV-1 (NL4-3)AF324493Vpu139GAAAGAGCAGAAGACAGUGGC85.00840(56.15%)HEK 293a19497094
1487HIV-1 (NL4-3)AF324493Vpu140AAAGAGCAGAAGACAGUGGC-56.00841(56.22%)HEK 293a19497094
1488HIV-1 (NL4-3)AF324493Vpu140AAAGAGCAGAAGACAGUGGCA32.60841(56.22%)HEK 293a19497094
1489HIV-1 (NL4-3)AF324493Vpu141AAGAGCAGAAGACAGUGGCA91.50849(56.75%)HEK 293a19497094
1490HIV-1 (NL4-3)AF324493Vpu143GAGCAGAAGACAGUGGCAAU89.90895(59.83%)HEK 293a19497094
1491HIV-1 (NL4-3)AF324493Vpu144AGCAGAAGACAGUGGCAAUG78.60896(59.89%)HEK 293a19497094
1492HIV-1 (NL4-3)AF324493Vpu144AGCAGAAGACAGUGGCAAUGA86.00892(59.63%)HEK 293a19497094
1493HIV-1 (NL4-3)AF324493Vpu145GCAGAAGACAGUGGCAAUGA92.30917(61.30%)HEK 293a19497094
1494HIV-1 (NL4-3)AF324493Vpu146CAGAAGACAGUGGCAAUGAG88.30801(53.54%)HEK 293a19497094
1495HIV-1 (NL4-3)AF324493Vpu147AGAAGACAGUGGCAAUGAGAG94.20835(55.82%)HEK 293a19497094
1496HIV-1 (NL4-3)AF324493Vpu148GAAGACAGUGGCAAUGAGAGU91.80757(50.60%)HEK 293a19497094
1497HIV-1 (NL4-3)AF324493Vpu149AAGACAGUGGCAAUGAGAGU89.70758(50.67%)HEK 293a19497094